Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
June 04 2019 - 8:00AM
Business Wire
Apyx Medical Corporation, formerly Bovie Medical
Corporation, (NASDAQ:APYX) (the “Company”), a maker of
medical devices and supplies and the developer of J-Plasma®, a
patented surgical product marketed and sold under the Renuvion®
Cosmetic Technology brand in the cosmetic surgery market, today
announced that management will participate in the JMP Securities
Life Sciences Conference at the St. Regis New York Hotel in New
York, NY. Management will participate in a fireside chat on
Thursday, June 20 at 1:00 p.m. Eastern Time.
A live audio webcast of the presentation will be provided under
the ‘Company Events’ section of the Apyx Medical Corporation
investor relations website at
https://apyxmedical.com/investor_relations/. An archive of the
webcast will be available for replay following the conferences.
About Apyx Medical
Corporation:
Apyx Medical Corporation (formerly Bovie Medical Corporation) is
an advanced energy technology company with a passion for elevating
people’s lives through innovative products in the cosmetic and
surgical markets. Known for its innovative Helium Plasma
Technology, Apyx is solely focused on bringing transformative
solutions to the physicians and patients it serves. The company’s
Helium Plasma Technology is marketed and sold as Renuvion® in the
cosmetic surgery market and J-Plasma® in the hospital surgical
market. Renuvion offers plastic surgeons, fascial plastic surgeons
and cosmetic physicians a unique ability to provide controlled heat
to the tissue to achieve their desired results. The J-Plasma system
allows surgeons to operate with a high level of precision and
virtually eliminating unintended tissue trauma. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through original equipment manufacturing (OEM) agreements
with other medical device manufacturers. For further information
about the Company and its products, please refer to the Apyx
Medical Corporation website at www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190604005136/en/
Investor Relations
Contact:Westwicke Partners on behalf of Apyx
Medical CorporationMike Piccinino,
CFAinvestor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Sep 2023 to Sep 2024